1-204997300-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_ModerateBP6_ModerateBP7BS1
The NM_001005388.3(NFASC):c.2913C>T(p.Ile971Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000281 in 1,602,514 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000053 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000026 ( 0 hom. )
Consequence
NFASC
NM_001005388.3 synonymous
NM_001005388.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.189
Publications
19 publications found
Genes affected
NFASC (HGNC:29866): (neurofascin) This gene encodes an L1 family immunoglobulin cell adhesion molecule with multiple IGcam and fibronectin domains. The protein functions in neurite outgrowth, neurite fasciculation, and organization of the axon initial segment (AIS) and nodes of Ranvier on axons during early development. Both the AIS and nodes of Ranvier contain high densities of voltage-gated Na+ (Nav) channels which are clustered by interactions with cytoskeletal and scaffolding proteins including this protein, gliomedin, ankyrin 3 (ankyrin-G), and betaIV spectrin. This protein links the AIS extracellular matrix to the intracellular cytoskeleton. This gene undergoes extensive alternative splicing, and the full-length nature of some variants has not been determined.[provided by RefSeq, May 2009]
NFASC Gene-Disease associations (from GenCC):
- neurodevelopmental disorder with central and peripheral motor dysfunctionInheritance: AR, AD Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 1-204997300-C-T is Benign according to our data. Variant chr1-204997300-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 2639843.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.189 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0000527 (8/151936) while in subpopulation AMR AF = 0.000459 (7/15266). AF 95% confidence interval is 0.000215. There are 0 homozygotes in GnomAd4. There are 5 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NFASC | ENST00000339876.11 | c.2913C>T | p.Ile971Ile | synonymous_variant | Exon 25 of 30 | 5 | NM_001005388.3 | ENSP00000344786.6 | ||
| NFASC | ENST00000539706.6 | c.3136+5994C>T | intron_variant | Intron 25 of 27 | 5 | NM_001160331.2 | ENSP00000438614.2 |
Frequencies
GnomAD3 genomes AF: 0.0000527 AC: 8AN: 151936Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
8
AN:
151936
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000671 AC: 15AN: 223492 AF XY: 0.0000655 show subpopulations
GnomAD2 exomes
AF:
AC:
15
AN:
223492
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000255 AC: 37AN: 1450578Hom.: 0 Cov.: 37 AF XY: 0.0000347 AC XY: 25AN XY: 720878 show subpopulations
GnomAD4 exome
AF:
AC:
37
AN:
1450578
Hom.:
Cov.:
37
AF XY:
AC XY:
25
AN XY:
720878
show subpopulations
African (AFR)
AF:
AC:
0
AN:
33134
American (AMR)
AF:
AC:
5
AN:
42734
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25926
East Asian (EAS)
AF:
AC:
0
AN:
38734
South Asian (SAS)
AF:
AC:
15
AN:
85176
European-Finnish (FIN)
AF:
AC:
0
AN:
52300
Middle Eastern (MID)
AF:
AC:
2
AN:
5758
European-Non Finnish (NFE)
AF:
AC:
14
AN:
1106918
Other (OTH)
AF:
AC:
1
AN:
59898
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000527 AC: 8AN: 151936Hom.: 0 Cov.: 31 AF XY: 0.0000674 AC XY: 5AN XY: 74210 show subpopulations
GnomAD4 genome
AF:
AC:
8
AN:
151936
Hom.:
Cov.:
31
AF XY:
AC XY:
5
AN XY:
74210
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41352
American (AMR)
AF:
AC:
7
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3466
East Asian (EAS)
AF:
AC:
0
AN:
5158
South Asian (SAS)
AF:
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
AC:
0
AN:
10584
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
1
AN:
67972
Other (OTH)
AF:
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
May 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
NFASC: BP4, BP7 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.